Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study
Authors
Keywords
-
Journal
Cancer Medicine
Volume 10, Issue 10, Pages 3165-3176
Publisher
Wiley
Online
2021-05-01
DOI
10.1002/cam4.3763
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial
- (2020) Lei Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia
- (2019) Xiao-Ning Gao et al. ANNALS OF HEMATOLOGY
- Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS
- (2019) Sousuke Nakamura et al. BLOOD
- Epigenetic modifier gene mutations‐positive AML patients with intermediate‐risk karyotypes benefit from decitabine with CAG regimen
- (2019) Qingyu Xu et al. INTERNATIONAL JOURNAL OF CANCER
- Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Martin S. Tallman et al. Journal of the National Comprehensive Cancer Network
- Conditioning Regimen of 5-Day Decitabine Administration for Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome and Myeloproliferative Neoplasms
- (2019) Yi-Geng Cao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
- (2019) Diego Carbonell et al. Cancers
- Impact of the variant allele frequency of ASXL1 , DNMT3A , JAK2 , TET2 , TP53 , and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia
- (2019) Koji Sasaki et al. CANCER
- Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease
- (2019) Qing Ya Wang et al. Cancer Management and Research
- ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics
- (2018) Katerina Kakosaiou et al. LEUKEMIA & LYMPHOMA
- Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
- (2018) Xiao-Ning Gao et al. ANNALS OF HEMATOLOGY
- Measurable residual disease (MRD) monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
- (2018) Felicitas Thol et al. BLOOD
- Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
- (2018) John De Vos et al. BULLETIN DU CANCER
- FLT3–ITD and its current role in acute myeloid leukaemia
- (2017) Francisco Alejandro Lagunas-Rangel et al. MEDICAL ONCOLOGY
- Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
- (2017) R. Coleman Lindsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia
- (2017) Alberto Ponciano-Gómez et al. TUMOR BIOLOGY
- Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing
- (2017) Yuanyuan Xu et al. Oncotarget
- Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3 -ITD Allelic Ratio in FLT3 -ITD–Positive Acute Myelogenous Leukemia
- (2016) Betül Oran et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- TP53mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation
- (2016) Jan M. Middeke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies
- (2016) Hong-Hua Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
- (2016) A Stengel et al. LEUKEMIA
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2016) John S. Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing
- (2016) Bianhong Wang et al. Oncotarget
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- (2015) Iskra Pusic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT
- (2015) X Chang et al. BONE MARROW TRANSPLANTATION
- Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome
- (2015) Seunghoon Han et al. Journal of Hematology & Oncology
- Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis
- (2014) Wen-Jian Liu et al. LEUKEMIA & LYMPHOMA
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia
- (2013) Usama Gergis et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
- (2013) Gita Thanarajasingam et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
- (2013) V. I. Gaidzik et al. BLOOD
- A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes
- (2013) F Locke et al. BONE MARROW TRANSPLANTATION
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen
- (2012) Maria Liga et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
- (2012) O. C. Goodyear et al. BLOOD
- Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
- (2012) Salut Brunet et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Allogeneic Transplantation for FLT3/ITD Acute Myeloid Leukemia: Outcomes from 133 Consecutive Newly Diagnosed Patients from a Single Institution
- (2011) Amy E. DeZern et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
- (2011) F. G. Rucker et al. BLOOD
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
- (2010) J. Choi et al. BLOOD
- Regression modeling of competing risk using R: an in depth guide for clinicians
- (2010) L Scrucca et al. BONE MARROW TRANSPLANTATION
- The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia
- (2009) H Seifert et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started